Literature DB >> 2189309

Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism.

G S Levey1, I Klein.   

Abstract

The spectrum of classic symptoms of hyperthyroidism suggests that in addition to the effects of increased thyroid hormone, affecting various organ systems, there is also a hyperadrenergic state. Despite this clinical impression, direct measures of serum levels of catecholamines and their urinary metabolites demonstrate values that are equal to or less than normal. In contrast, the hypothyroid patient who clinically manifests signs of decreased adrenergic stimulation can be expected to have increased levels of epinephrine, norepinephrine, and its metabolites. This review discusses possible mechanisms to explain this seeming paradox. Treatment of hyperthyroidism includes the rapid reversal of many of the adrenergic symptoms with use of beta-blocking drugs. Return to a clinically and chemically euthyroid state, however, requires antithyroid therapy accomplished over a longer period of time. A knowledge of the interaction of the cardiovascular and extracardiovascular manifestations of hyperthyroidism and the role of the adrenergic nervous system is important in the rational management of these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189309     DOI: 10.1016/0002-9343(90)90533-j

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  31 in total

1.  Thyrotoxic periodic paralysis.

Authors:  Lien Lam; Rajasree J Nair; Leslie Tingle
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-04

2.  Heart failure in thyrotoxicosis, an approach to management.

Authors:  R P Choudhury; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

3.  Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying.

Authors:  M Barczyński; P Thor
Journal:  Clin Auton Res       Date:  2001-08       Impact factor: 4.435

4.  AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.

Authors:  Ana Paula Cremasco Takano; Nathalia Senger; Carolina Demarchi Munhoz; Maria Luiza Morais Barreto-Chaves
Journal:  Pflugers Arch       Date:  2017-11-25       Impact factor: 3.657

5.  Effect of triiodothyronine administration in experimental myocardial injury.

Authors:  R B Hsu; T S Huang; Y S Chen; S H Chu
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

6.  Thyrotoxic hypokalaemic periodic paralysis: a rare presentation of Graves' disease in a Hispanic patient.

Authors:  Abhishek Matta; Jahnavi Koppala; William Gossman
Journal:  BMJ Case Rep       Date:  2014-04-09

7.  Hemodynamic and tissue oxygenation responses to exercise and beta-adrenergic blockade in patients with hyperthyroidism.

Authors:  Maristela C Monachini; Silvia G Lage; Miguel A N Ran; Rita H A Cardoso; Caio Medeiros; Bruno Caramelli; Andrei C Sposito; José A F Ramires
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

Review 8.  Arrhythmia and thyroid dysfunction.

Authors:  S Marrakchi; F Kanoun; S Idriss; I Kammoun; S Kachboura
Journal:  Herz       Date:  2014-07-04       Impact factor: 1.443

9.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

10.  Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny.

Authors:  Egberto Gaspar de Moura; Isabela Teixeira Bonomo; José Firmino Nogueira-Neto; Elaine de Oliveira; Isis Hara Trevenzoli; Adelina Martha Reis; Magna Cottini Fonseca Passos; Patricia Cristina Lisboa
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.